HEADER HYDROLASE 03-OCT-13 4C9W TITLE CRYSTAL STRUCTURE OF NUDT1 (MTH1) WITH R-CRIZOTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: 7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 2-HYDROXY-DATP DIPHOSPHATASE, 8-OXO-DGTPASE, NUCLEOSIDE COMPND 5 DIPHOSPHATE-LINKED MOIETY X MOTIF 1, NUDIX MOTIF 1; COMPND 6 EC: 3.6.1.55, 3.6.1.56; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS HYDROLASE, CRIZOTINIB EXPDTA X-RAY DIFFRACTION AUTHOR J.M.ELKINS,E.SALAH,K.HUBER,G.SUPERTI-FURGA,K.R.ABDUL AZEEZ,J.RAYNOR, AUTHOR 2 T.KROJER,F.VON DELFT,C.BOUNTRA,A.EDWARDS,S.KNAPP REVDAT 4 20-DEC-23 4C9W 1 REMARK REVDAT 3 24-JAN-18 4C9W 1 AUTHOR REVDAT 2 16-APR-14 4C9W 1 JRNL REVDAT 1 02-APR-14 4C9W 0 JRNL AUTH K.V.M.HUBER,E.SALAH,B.RADIC,M.GRIDLING,J.M.ELKINS, JRNL AUTH 2 A.STUKALOV,A.JEMTH,C.GOKTURK,K.SANJIV,K.STROMBERG,T.PHAM, JRNL AUTH 3 U.W.BERGLUND,J.COLINGE,K.L.BENNETT,J.I.LOIZOU,T.HELLEDAY, JRNL AUTH 4 S.KNAPP,G.SUPERTI-FURGA JRNL TITL STEREOSPECIFIC TARGETING OF MTH1 BY (S)-CRIZOTINIB AS AN JRNL TITL 2 ANTICANCER STRATEGY. JRNL REF NATURE V. 508 222 2014 JRNL REFN ISSN 0028-0836 JRNL PMID 24695225 JRNL DOI 10.1038/NATURE13194 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 17128 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.152 REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 923 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1193 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.53 REMARK 3 BIN R VALUE (WORKING SET) : 0.1840 REMARK 3 BIN FREE R VALUE SET COUNT : 69 REMARK 3 BIN FREE R VALUE : 0.2450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1239 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 156 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.38000 REMARK 3 B22 (A**2) : -0.43000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.156 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.108 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.329 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1362 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1230 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1862 ; 1.348 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2841 ; 0.726 ; 3.004 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 169 ; 6.101 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 67 ;30.379 ;24.627 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 226 ;11.679 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;11.765 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 195 ; 0.074 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1547 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 322 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 631 ; 1.690 ; 1.305 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 630 ; 1.690 ; 1.304 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 791 ; 2.222 ; 1.965 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 792 ; 2.221 ; 1.965 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 730 ; 2.288 ; 1.680 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 711 ; 2.108 ; 1.627 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1034 ; 2.524 ; 2.326 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 1600 ; 3.896 ;12.981 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1538 ; 3.717 ;12.316 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2590 ; 2.294 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 52 ;28.595 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2660 ; 8.847 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4C9W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1290058628. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18113 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 44.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3ZR0 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 30%(W/V) PEG REMARK 280 4000, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.98000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.43500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.98000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.43500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -126.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -59.96000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CL CL A1157 LIES ON A SPECIAL POSITION. REMARK 375 S SO4 A1162 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 25 NE CZ NH1 NH2 REMARK 470 PHE A 27 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 114 CD CE NZ REMARK 470 LYS A 130 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2033 O HOH A 2034 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2152 O HOH A 2156 4544 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 62 -91.23 -90.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 VGH A 1158 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1157 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VGH A 1158 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1160 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1161 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1162 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1163 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NUDT1 (MTH1) WITH S-CRIZOTINIB REMARK 999 REMARK 999 SEQUENCE REMARK 999 P36639 ISOFORM 4 DBREF 4C9W A 1 156 UNP P36639 8ODP_HUMAN 1 156 SEQADV 4C9W GLY A -1 UNP P36639 EXPRESSION TAG SEQADV 4C9W ALA A 0 UNP P36639 EXPRESSION TAG SEQRES 1 A 158 GLY ALA MET GLY ALA SER ARG LEU TYR THR LEU VAL LEU SEQRES 2 A 158 VAL LEU GLN PRO GLN ARG VAL LEU LEU GLY MET LYS LYS SEQRES 3 A 158 ARG GLY PHE GLY ALA GLY ARG TRP ASN GLY PHE GLY GLY SEQRES 4 A 158 LYS VAL GLN GLU GLY GLU THR ILE GLU ASP GLY ALA ARG SEQRES 5 A 158 ARG GLU LEU GLN GLU GLU SER GLY LEU THR VAL ASP ALA SEQRES 6 A 158 LEU HIS LYS VAL GLY GLN ILE VAL PHE GLU PHE VAL GLY SEQRES 7 A 158 GLU PRO GLU LEU MET ASP VAL HIS VAL PHE CYS THR ASP SEQRES 8 A 158 SER ILE GLN GLY THR PRO VAL GLU SER ASP GLU MET ARG SEQRES 9 A 158 PRO CYS TRP PHE GLN LEU ASP GLN ILE PRO PHE LYS ASP SEQRES 10 A 158 MET TRP PRO ASP ASP SER TYR TRP PHE PRO LEU LEU LEU SEQRES 11 A 158 GLN LYS LYS LYS PHE HIS GLY TYR PHE LYS PHE GLN GLY SEQRES 12 A 158 GLN ASP THR ILE LEU ASP TYR THR LEU ARG GLU VAL ASP SEQRES 13 A 158 THR VAL HET CL A1157 1 HET VGH A1158 25 HET SO4 A1159 5 HET SO4 A1160 5 HET SO4 A1161 5 HET SO4 A1162 5 HET SO4 A1163 5 HETNAM CL CHLORIDE ION HETNAM VGH 3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-(1- HETNAM 2 VGH PIPERIDIN-4-YL-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE HETNAM SO4 SULFATE ION HETSYN VGH CRIZOTINIB FORMUL 2 CL CL 1- FORMUL 3 VGH C21 H22 CL2 F N5 O FORMUL 4 SO4 5(O4 S 2-) FORMUL 9 HOH *156(H2 O) HELIX 1 1 THR A 44 GLY A 58 1 15 HELIX 2 2 ASP A 109 ILE A 111 5 3 HELIX 3 3 PRO A 112 ASP A 115 5 4 HELIX 4 4 ASP A 119 GLN A 129 1 11 SHEET 1 AA 2 TRP A 32 ASN A 33 0 SHEET 2 AA 2 ARG A 17 LYS A 23 1 O GLY A 21 N ASN A 33 SHEET 1 AB 2 PHE A 35 LYS A 38 0 SHEET 2 AB 2 SER A 4 LEU A 13 -1 O THR A 8 N GLY A 37 SHEET 1 AC 2 MET A 101 GLN A 107 0 SHEET 2 AC 2 ARG A 17 LYS A 23 -1 O VAL A 18 N PHE A 106 SHEET 1 AD 7 THR A 144 VAL A 153 0 SHEET 2 AD 7 LYS A 132 GLN A 140 -1 O LYS A 132 N VAL A 153 SHEET 3 AD 7 HIS A 65 PHE A 74 1 O VAL A 67 N PHE A 133 SHEET 4 AD 7 LEU A 80 THR A 88 -1 O MET A 81 N PHE A 72 SHEET 5 AD 7 SER A 4 LEU A 13 1 O ARG A 5 N ASP A 82 SHEET 6 AD 7 ARG A 17 LYS A 23 -1 O LEU A 19 N VAL A 12 SHEET 7 AD 7 TRP A 32 ASN A 33 1 O ASN A 33 N GLY A 21 SHEET 1 AE 6 THR A 144 VAL A 153 0 SHEET 2 AE 6 LYS A 132 GLN A 140 -1 O LYS A 132 N VAL A 153 SHEET 3 AE 6 HIS A 65 PHE A 74 1 O VAL A 67 N PHE A 133 SHEET 4 AE 6 LEU A 80 THR A 88 -1 O MET A 81 N PHE A 72 SHEET 5 AE 6 SER A 4 LEU A 13 1 O ARG A 5 N ASP A 82 SHEET 6 AE 6 PHE A 35 LYS A 38 -1 O PHE A 35 N VAL A 10 SHEET 1 AF 2 THR A 60 VAL A 61 0 SHEET 2 AF 2 ILE A 91 GLN A 92 -1 O GLN A 92 N THR A 60 SITE 1 AC1 3 TYR A 148 THR A 149 HOH A2140 SITE 1 AC2 11 TYR A 7 PHE A 27 ASN A 33 PHE A 72 SITE 2 AC2 11 PHE A 74 MET A 81 VAL A 83 TRP A 117 SITE 3 AC2 11 ASP A 119 ASP A 120 HOH A2031 SITE 1 AC3 6 HIS A 65 LYS A 66 HOH A2049 HOH A2076 SITE 2 AC3 6 HOH A2077 HOH A2082 SITE 1 AC4 5 HIS A 65 THR A 88 ASP A 89 SER A 90 SITE 2 AC4 5 HOH A2095 SITE 1 AC5 4 HIS A 134 ARG A 151 HOH A2020 HOH A2154 SITE 1 AC6 3 LYS A 138 ASP A 147 HOH A2102 SITE 1 AC7 9 PRO A 95 ARG A 151 VAL A 153 ASP A 154 SITE 2 AC7 9 THR A 155 HOH A2019 HOH A2111 HOH A2152 SITE 3 AC7 9 HOH A2155 CRYST1 36.200 59.960 66.870 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027624 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016678 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014954 0.00000